Maqola

Digital therapeutics and gamified mobile applications for behavioral modification in pediatric hypertension

Berdiyarova Shokhida- assistant of the department of Clinical laboratory diagnostics with the course of clinical laboratory diagnostics of PGD, Samarkand state medical university, Samarkand, Uzbekistan;Rakhmatova R. MarkhaboPhD, Associate Professor of the department clinic pharmacology, Bukhara State Medical Institute, Bukhara, Uzbekistan;Uzbekova NelliDoctor of Medicine, Associate Professor, of the department of faculty therapy, Andijan State Medical Institute, UzbekistanKhakimova Lazizasenior teacher, Tashkent University of Information Technologies named after Muhammad al-Khwarizmi, Tashkent, UzbekistanRano IsmaylovaCandidate of Psychological Sciences, Associate Professor of the Department of Psychology, Alfraganus University, Tashkent, UzbekistanNigora Mamatova- Senior teacher of the Department of Fashion Design at the Tashkent Institute of Textile and Light Industry, UzbekistanMansurova MalikaAssistant professor of the Department of Microbiology, Virology and Immunology, Bukhara state medical institute, Bukhara, Republic of UzbekistanShohista Matyakubovahead teacher, Department of Psychology, Applied science university of Tashkent, Republic of UzbekistanErgasheva Nodiraxonassistant, Ferghana Medical Institute of Public Health, Ferghana, Respublic of UzbekistanJabbarov FakhriddinLecturer, Termez university of Economy and Service, Termiz, Uzbekistan

Open MINDrepository2026en

ABI

Annotatsiya

Hypertension in children is a growing global health concern, particularly in regions undergoing lifestyle transitions. This pilot study evaluated the effectiveness of "PressPlay Kids," a culturally-adapted, gamified mobile health application, for behavioral modification in children and adolescents with hypertension in Uzbekistan. We conducted a 12-week randomized controlled trial involving 80 participants aged 10-16, comparing the app combined with standard counseling to standard counseling alone. Participants in the intervention group showed a significantly greater reduction in systolic blood pressure compared to controls (-8.2 mmHg vs. -2.1 mmHg, p < 0.001). Significant improvements were also observed in key behavioral outcomes: daily sodium intake decreased by a median of 500 mg in the intervention group (p < 0.001), daily step count increased by over 2,000 steps (p < 0.001), and medication adherence was 22% higher among those prescribed pharmacotherapy (p = 0.009). App engagement was high, with participants logging in an average of 5.8 times per week, and 86.8% reported the app as "fun" or "very fun" to use.

Hali tarjima qilinmagan

Mavzular

Mobile Health and mHealth Applications Blood Pressure and Hypertension Studies Sodium Intake and Health

Identifikatorlar

DOI: 10.5281/zenodo.18626596

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba

Koʻrsatkichlar — AkademScholar · Tez orada